scholarly journals Resection of the Gastric Tube Reconstructed through the Retrosternal Route without Sternotomy

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Masahiro Kimura ◽  
Yasuyuki Shibata ◽  
Kotaro Mizuno ◽  
Hironori Tanaka ◽  
Motoki Hato ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Esophageal Cancer ◽  
Gastric Tube ◽  
Early Stage ◽  
Combined Modality Therapy ◽  
First Report ◽  
Gastric Tube Cancer ◽  
Subtotal Esophagectomy ◽  
Combined Modality ◽  
Advanced Stages

With advances of combined modality therapy, prognoses in esophageal cancer have been improving. After resection of esophageal cancer, the development of gastric tube cancer is a risk. While such cancer in an early stage can be cured endoscopically, total gastric tube resection is indicated in advanced stages. A 68-year-old man underwent subtotal esophagectomy reconstructed with a gastric tube through the retrosternal route. Gastric cancer was found one and a half years postoperatively. The gastric tube was resected without sternotomy. This is the first report of a patient undergoing resection of the gastric tube reconstructed through the retrosternal route without sternotomy.

PS02.204: GASTRIC TUBE CANCER AFTER ESOPHAGECTOMY FOR ESOPHAGEAL CANCER: A SYSTEMATIC REVIEW

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 180-180
Author(s):  
Damiano Gentile ◽  
Pietro Riva ◽  
Anna Da Roit ◽  
Silvia Basato ◽  
Salvatore Marano ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Gastric Tube ◽  
Conflicts Of Interest ◽  
Case Reports ◽  
Treatment Strategies ◽  
Vocal Cord Palsy ◽  
Review Literature ◽  
Gastric Tube Cancer ◽  
Publication Number

Abstract Background Gastric conduit used for reconstruction after esophagectomy for esophageal cancer (EC) has the potential to develop a metachronous cancer known as gastric tube cancer (GTC). The aim of our study was to review literature and evaluate outcomes and possible treatment strategies for GTC. Methods A comprehensive systematic literature search was conducted using PubMed. No restriction was set for type of publication, number, age and sex of patients. Study language was limited to English. Characteristics of EC and its treatment and GTC and its treatment were analyzed. Results A total of 26 studies were analyzed, 10 retrospective analysis and 16 case reports, involving 170 patients, 17 patients (10%) were affected by multifocal GTC. 143 ECs (84,1%) were squamous cell carcinomas. In 95 patients (55,9%) a posterior-mediastinal reconstructive route was used at the time of esophagectomy for EC. Mean interval between esophagectomy and diagnosis of GTC was 67,18 months (4–236 months). 184 GTCs were metachronous lesions (98,4%). 164 GTCs were adenocarcinomas (98,2%). 84 GTCs were located in the lower part of the gastric tube. 88 patients were endoscopically treated. 63 patients underwent surgery. 30 total gastrectomies + limphoadenectomy with colon or jejunal interposition were performed. 27 subtotal gastrectomies and 6 wedge resections were performed. Main reported post-operative complications were: anastomotic leak, vocal cord palsy and respiratory failure. 19 patients were treated with chemoradiotherapy and palliative care. 68,2% of endoscopically treated patients, 63,5% of surgically resected patients and 5,2% of patients who underwent chemoradiotherapy were alive at a mean follow-up of 25,5 months. Feasibility of endoscopic resections in patients diagnosed with superficial GTC has been established. Surgical treatment represents the preferred treatment modality in operable patients with locally invasive tumor. Patients treated with conservative therapy have a scarce prognosis. Conclusion Yearly endoscopic follow-up is of paramount importance in patients who underwent esophagectomy for EC with gastric tube reconstruction. At least, a 10-year endoscopic surveillance is recommended. Disclosure All authors have declared no conflicts of interest.

Combined modality therapy for esophageal cancer

1997 ◽  
Vol 7 (3) ◽  
pp. 15-23 ◽  
Author(s):  
Charles D. Blanke ◽  
Hak Choy ◽  
Steven D. Leach
Keyword(s):  
Esophageal Cancer ◽  
Combined Modality Therapy ◽  
Combined Modality

Assessment of Quality of Life in Patients With Esophageal Cancer After Combined Modality Therapy

2007 ◽  
Vol 69 (3) ◽  
pp. S584
Author(s):  
R.C. Miller ◽  
P.J. Atherton ◽  
B. Kabat ◽  
M. Fredericksen ◽  
C. Deschamps ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Esophageal Cancer ◽  
Combined Modality Therapy ◽  
Combined Modality

Combined modality therapy in esophageal cancer: The Memorial experience

2003 ◽  
Vol 21 (4) ◽  
pp. 228-232 ◽  
Author(s):  
Sibyl E. Anderson ◽  
Bruce D. Minsky ◽  
Manjit Bains ◽  
David P. Kelsen ◽  
David H. Ilson
Keyword(s):  
Esophageal Cancer ◽  
Combined Modality Therapy ◽  
Combined Modality
Sign in / Sign up

Export Citation Format

Share Document